124 related articles for article (PubMed ID: 37716484)
1. Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease.
Kaboli Z; Hosseini MJ; Sadighian S; Rostamizadeh K; Hamidi M; Manjili HK
Int J Pharm; 2023 Oct; 645():123418. PubMed ID: 37716484
[TBL] [Abstract][Full Text] [Related]
2. The effect of baicalein-loaded Y-shaped miktoarm copolymer on spatial memory and hippocampal expression of DHCR24, SELADIN and SIRT6 genes in rat model of Alzheimer.
Aghajanzadeh M; Andalib S; Danafar H; Rostamizadeh K; Sharafi A
Int J Pharm; 2020 Aug; 586():119546. PubMed ID: 32544519
[TBL] [Abstract][Full Text] [Related]
3. Preparation, Optimization, and Evaluation of Methoxy Poly(ethylene glycol)-
Mohamadpour H; Azadi A; Rostamizadeh K; Andalib S; Saghatchi Zanjani MR; Hamidi M
ACS Chem Neurosci; 2020 Mar; 11(5):783-795. PubMed ID: 32043866
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
[TBL] [Abstract][Full Text] [Related]
5. PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer's disease: in vitro and in vivo studies.
Silva-Abreu M; Calpena AC; Andrés-Benito P; Aso E; Romero IA; Roig-Carles D; Gromnicova R; Espina M; Ferrer I; García ML; Male D
Int J Nanomedicine; 2018; 13():5577-5590. PubMed ID: 30271148
[TBL] [Abstract][Full Text] [Related]
6. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
[TBL] [Abstract][Full Text] [Related]
8. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
9. Effects of block copolymer properties on nanocarrier protection from in vivo clearance.
D'Addio SM; Saad W; Ansell SM; Squiers JJ; Adamson DH; Herrera-Alonso M; Wohl AR; Hoye TR; Macosko CW; Mayer LD; Vauthier C; Prud'homme RK
J Control Release; 2012 Aug; 162(1):208-17. PubMed ID: 22732478
[TBL] [Abstract][Full Text] [Related]
10. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
11. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic Y shaped miktoarm star copolymer for anticancer hydrophobic and hydrophilic drugs codelivery: Synthesis, characterization, in vitro, and in vivo biocompatibility study.
Aghajanzadeh M; Zamani M; Rashidzadeh H; Rostamizadeh K; Sharafi A; Danafar H
J Biomed Mater Res A; 2018 Nov; 106(11):2817-2826. PubMed ID: 29908009
[TBL] [Abstract][Full Text] [Related]
13. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
Liu Y; An S; Li J; Kuang Y; He X; Guo Y; Ma H; Zhang Y; Ji B; Jiang C
Biomaterials; 2016 Feb; 80():33-45. PubMed ID: 26706474
[TBL] [Abstract][Full Text] [Related]
14. Investigation of cationized triblock and diblock poly(ε-caprolactone)-co-poly(ethylene glycol) copolymers for oral delivery of enoxaparin: In vitro approach.
Charoongchit P; Suksiriworapong J; Mao S; Sapin-Minet A; Maincent P; Junyaprasert VB
Acta Biomater; 2017 Oct; 61():180-192. PubMed ID: 28782723
[TBL] [Abstract][Full Text] [Related]
15. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
16. Particle Integrity and Size Effect on the Journey of Polymeric Nanocarriers in Zebrafish Model and the Correlation with Mice.
Tao J; Wei Z; Xu M; Xi L; Cheng Y; Lee SM; Ge W; Zheng Y
Small; 2021 Oct; 17(43):e2103584. PubMed ID: 34528394
[TBL] [Abstract][Full Text] [Related]
17. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and Biochemical Implications of Dendrimeric Rivastigmine in Memory-Deficit and Alzheimer's Induced Rodents.
Gothwal A; Singh H; Jain SK; Dutta A; Borah A; Gupta U
ACS Chem Neurosci; 2019 Aug; 10(8):3789-3795. PubMed ID: 31257860
[TBL] [Abstract][Full Text] [Related]
19. Targeted drug delivery
Zamani M; Aghajanzadeh M; Sharafi A; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2022 Jan; 27(1):19-24. PubMed ID: 34895033
[TBL] [Abstract][Full Text] [Related]
20. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease.
Sun D; Li N; Zhang W; Zhao Z; Mou Z; Huang D; Liu J; Wang W
Colloids Surf B Biointerfaces; 2016 Dec; 148():116-129. PubMed ID: 27591943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
